Illinois 2025-2026 Regular Session

Illinois House Bill HB3530

Introduced
2/7/25  

Caption

HEALTH-TECH

Impact

The impact of HB3530 on state laws is minimal given its technical nature. It primarily serves to refine the language used in the Food, Drug and Cosmetic Act without altering its core provisions or the framework governing health and safety in Illinois. By simplifying the legislative language, it aims to improve understanding and compliance among stakeholders, including businesses involved in food and drug manufacturing and distribution.

Summary

House Bill 3530, introduced by Rep. Kam Buckner, aims to make a technical amendment to the Illinois Food, Drug and Cosmetic Act. The bill primarily addresses the phrasing regarding the short title of the Act, ensuring that it is in alignment with current legislative standards. This type of amendment is typically not contentious, as it does not introduce substantial changes in policy or regulatory frameworks but rather clarifies existing regulations.

Contention

There are no notable points of contention surrounding HB3530 as it is characterized as a straightforward technical change. Typically, such amendments pass without significant debate. However, it is important to note that technical amendments can sometimes spark discussions in committee regarding broader regulatory practices or the effectiveness of the current laws governing health and safety, even if they are not explicitly addressed in this particular bill.

Companion Bills

No companion bills found.

Previously Filed As

IL HB3759

IL FDA-PROHIBIT DRUG PAY OFF

IL SB0093

PROHIBITED FOOD ADDITIVES

IL SB1775

HEMP REGULATION REFORM

IL HB0064

HEMP REGULATION REFORM

IL SB1036

HEALTH-TECH

IL SB1042

HEALTH-TECH

IL SB1033

HEALTH-TECH

IL SB1034

HEALTH-TECH

IL HB2771

DPH-CERTIFICATE FEES

IL HB3454

EPINEPHRINE DELIVERY DEVICE

Similar Bills

No similar bills found.